You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Biologic Event Identification and Geolocation Unattended Ground Sensor
SBC: STREAMLINE AUTOMATION LLC Topic: SOCOM06018The DoD Chemical, Biological, Radiological, and Nuclear Defense Program Performance Plan discusses the status of sensing technologies and long-term goals, and shows point biological detection systems are expected to provide 20% of the objective capabilities in FY15. This indicates that there is the need for a man-portable, disposable, rapidly responding biological agent point detector that is cap ...
SBIR Phase I 2007 Department of DefenseSpecial Operations Command -
Development of a Database Management System to Enable Rapid, Efficient Assay Design for Use in Detection and Diagnosis of Human Exposure to Biological
SBC: CFD RESEARCH CORPORATION Topic: CBD07114The primary objective of this effort is to design and develop a database management system (DBMS) and enable the integrated interpretation of the vast amounts of genomic and proteomic data in proper biological context. This DBMS will enable the development of diagnostic assays for human exposure to specific biological threat agents using an existing suite of systems biology tools. The DBMS design ...
SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense -
Multiple Indication Adjuvants
SBC: BIOPROTECTION SYSTEMS CORP. Topic: CBD08105The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vaccine candidates for the select Category A viral pathogens Zaire ebolavirus (ZEBOV, filovirus), Rift Valley fever virus (RVFV, bunyavirus), and Lassa virus (LV, arenavirus), to evaluate the adjuvant pot ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense